Form D — NexPoint Life Sciences II DST
0001980223-25-000004 · filed Nov 7, 2025
Offering
- Industry
- Other Real Estate
- Exemptions
- 06c, 3C, 3C.5
- Total offering
- $40,489,695
- Total sold
- $39,563,756
- Minimum investment
- $100,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- NexPoint Life Sciences II DST
- CIK
- 1980223
- Entity
- Other
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 300 CRESCENT COURT
DALLAS, TX 75201 - Phone
- 833-697-6246
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
N/A NexPoint Real Estate Advisors IV, L.P. · Executive OfficerDallas, TX Find on LinkedIn ↗
-
Matthew Goetz · Executive OfficerDallas, TX Find on LinkedIn ↗
-
N/A NREA Life Sciences II, LLC · Executive OfficerDallas, TX Find on LinkedIn ↗
-
N/A NREA LS II Investment Co, LLC · Executive OfficerDallas, TX Find on LinkedIn ↗
-
Matt McGraner · Executive OfficerDallad, TX Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗